Peptide MYOSTATIN GDF-8 [3mg] – 3 Vials – Meditech

57 USD

Laboratory: Meditech
Form: Subcutaneous injection
Molecule: GDF-8 Recombinant Myostatin
Concentration: 1mg/vial
Volume: 3 vials
Recommended Dosage: 0.5 per injection, daily.

MYOSTATIN GDF-8 [1mg] is a recombinant peptide that inhibits myostatin, promoting muscle growth, increased strength, and faster recovery. It has potential therapeutic uses for muscle-wasting diseases and conditions.

Category:

Description

Description and Effects

MYOSTATIN GDF-8 [1mg x 3 vials] is a recombinant peptide that targets the inhibition of myostatin, a protein that limits muscle growth. By blocking myostatin activity, this peptide promotes increased muscle mass, enhanced strength, and faster muscle recovery. MYOSTATIN GDF-8 has potential therapeutic applications for treating various muscle-wasting diseases and conditions, offering a pathway for improving muscle health and function.

Key Benefits of the Product

  • Increased Muscle Mass : Stimulates muscle growth by inhibiting myostatin, allowing for greater muscle development.
  • Enhanced Strength : Promotes improved muscle strength and physical performance.
  • Improved Muscle Recovery : Speeds up muscle recovery after intense physical activity, helping athletes and individuals regain strength more quickly.
  • Potential to Treat Muscle-Wasting Diseases : Offers potential therapeutic benefits for conditions such as muscular dystrophy, sarcopenia, and other muscle-wasting conditions.

Usage Guidelines

  • Recommended Dosage : Typically 0.5 mg per injection, once a day, based on individual goals and medical advice.
  • Duration of Use : Common cycles last 8 to 12 weeks, with breaks between cycles as needed.
  • Injection Method : Administer subcutaneously, preferably in the abdominal region or fatty tissue.

Precautions and Well-being

  • Possible Side Effects : Mild irritation or swelling at the injection site may occur. Serious side effects are rare but should be monitored.
  • Responsible Use : Adhere to recommended dosages and cycles to avoid unnecessary risks or adverse effects.
  • Regular Monitoring : Regular progress tracking and consultations with a healthcare professional are advised to adjust the dosage as needed.
  • Injection Hygiene : Always use sterile needles and follow proper injection techniques to prevent infections.